扩大生物膜生物反应器的规模,以提高menaquinone-7的产量
Aydin Berenjian1,2, Ehsan Mahdinia3, Ali Demirci4
1Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, 80523, USA.
Bioprocess and biosystems engineering
|April 5, 2025
概括
使用生物膜反应堆扩大menaquinone-7 (MK-7) 的生产是可行的. 这项研究成功地将该过程扩大到30-L,实现了高MK-7产量,特别是在养批量策略下.
科学领域:
- 生物技术是生物技术.
- 微生物发酵 微生物发酵
- 营养科学 营养科学
背景情况:
- menaquinone-7 (MK-7) 具有显著的健康益处,通常通过发酵产生.
- 现有的MK-7生产方法面临着可扩展性挑战.
- 使用Bacillus subtilis natto的生物膜反应器为MK-7生物合成提供了一种新的方法.
研究的目的:
- 扩大一个创新的生物膜反应器,用于MK-7生产,从2L扩大到30L.
- 为了评估氧气质量转移,输入功率和推进器尖端速度对MK-7产量的影响.
- 调查料批量策略在试点规模反应堆中增强MK-7生产的有效性.
主要方法:
- 在塑料复合材料支上使用Bacillus subtilis natto开发并扩展了一个生物膜反应器.
- 评估了三个扩展策略:恒定体积氧气质量转移系数 (kLa),每单位体积的振动输入功率 (P/V) 和推进器尖端速度 (Vtip).
- 在30L试验级反应堆中实施了料批次葡萄糖添加策略.
主要成果:
- 在扩展过程中保持恒定的kLa被证明是MK-7生产中最有效的,在30-L时达到21.0 ± 1.0 mg/L.
- 食批量策略显著提高了MK-7度,达到28.7 ± 0.3 mg/L,比悬浮细胞生物反应器增加了2.3倍.
- 生物膜反应器技术成功展示了可扩展性和商业MK-7生产的潜力.
结论:
- 生物膜反应器技术可用于商业MK-7生产.
- 保持一致的kLa对于成功的扩展至关重要.
- 在生物膜反应堆中,储存批量策略在增加MK-7产量方面具有显著的优势,超过了传统方法.
更多相关视频
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
9.9K
08:41Microalgae Cultivation and Biomass Quantification in a Bench-Scale Photobioreactor with Corrosive Flue Gases
Published on: December 19, 2019
10.1K
相关概念视频
Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Bioreactor Controls-II
In aerobic fermentations, oxygen is vital for microbial growth and metabolite production. Since air comprises only about 20% oxygen and the gas is poorly soluble in water—just 9 ppm at 20°C—supplying sufficient oxygen becomes a critical challenge, especially in high-demand processes like yeast growth or citric acid production. Even a fully saturated broth may offer only a few seconds of oxygen availability.To address this, sterile or scrubbed air is introduced into the fermentor via a sparger...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Designing Growth Media for Bioreactors
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
